Hormone spray Lenzetto removed from
Photo: Hasse Holmberg/TT

Hormone spray Lenzetto removed from high-cost drug subsidy

The estrogen spray Lenzetto will no longer be included in the high-cost drug subsidy as of April 1. This means the medication will become more expensive but, at the same time, more accessible.

TV4 Nyheterna reports that the Dental and Pharmaceutical Benefits Agency, the authority that decides which medicines should be subsidized in Sweden, wanted the manufacturer to lower the price, but instead the price has been raised.

TLV is pushing down the prices of medicines, which means that companies choose to move production to other countries where they can make more money, says gynecologist and researcher Helena Kopp Kallner, calling the decision "a disaster for Swedish women."

The spray has been removed from subsidy coverage in large parts of the country, but the company has said that when the preparation is no longer subsidized by the state it will become more readily available.

In this story
AuthorTT News AgencyEnglish edition by Sweden Herald, adapted for our readers
Was this useful?

What do you think?

Keep readingmore from Sweden

All